Cover Image
市場調查報告書

全球男性不孕市場

Global Male Infertility Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 321458
出版日期 內容資訊 英文 70 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球男性不孕市場 Global Male Infertility Market 2017-2021
出版日期: 2017年03月10日 內容資訊: 英文 70 Pages
簡介

全球男性不孕治療市場,預計從2014年到2019年之間,以6.60%的CAGR(年複合成長率)擴大。

本報告提供全球男性不孕市場現狀及未來預測、市場成長因素和課題、主要企業分析等。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 疾病概要

  • 男性不孕
    • 病因
    • 徵兆與症狀
    • 治療方法
    • 診斷

第6章 簡介

第7章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第8章 各技術的市場區隔

第9章 地理區隔

  • 南北美洲的男性不孕市場
  • 歐洲、中東、非洲地區的男性不孕市場
  • 亞太地區的男性不孕市場

第10章 購買標準

第11章 市場成長因素

第12章 成長因素與其影響

第13章 市場課題

第14章 成長因素與課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 業者情勢

  • 競爭模式
    • 主要消息
    • M&A
  • 市場佔有率分析

第18章 主要供應商分析

  • CooperSurgical Inc
  • Elelixis Diagnostics SA
  • Halotech DNA SL
  • Medical Electronic Systems LLC

第19章 相關報告

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR12215

About Male Infertility

Male infertility is a widespread disorder, which refers to a male's inability to impregnate his fertile female partner. It occurs due to deficiencies in semen, poor sperm quality, lower hormonal support, and abnormal ejaculation.

Technavio's analysts forecast the global male infertility market to grow at a CAGR of 5.68% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global male infertility market for 2017-2021. To calculate the market size, the report considers the male infertility treatment, which includes products (drugs) and services.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Male Infertility Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • ASKA Pharmaceutical
  • Halotech DNA
  • Merck Serono
  • Zydus Cadila Healthcare
  • Other prominent vendors
  • AbbVie
  • Apricus Biosciences
  • Aytu BioScience
  • Bristol-Myers Squibb
  • CooperSurgical
  • Medical Electronic Systems
  • OvaScience
  • MedITEX
  • Xytex Cryo International

Market driver

  • Higher occurrence of diabetes among men
  • For a full, detailed list, view our report

Market challenge

  • High cost associated with treatment of male infertility
  • For a full, detailed list, view our report

Market trend

  • Monetary growth among consumers
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
  • You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by under-lying cause

PART 07: Market segmentation by technique

PART 08: Market segmentation by end-user

  • Market overview
  • Fertility clinics
  • Hospitals and research institutes

PART 09: Geographical segmentation

  • Market overview
  • Male infertility market in Americas
  • Male infertility market in EMEA
  • Male infertility market in APAC

PART 10: Decision framework

PART 11: Market drivers

  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments

PART 12: Market trends

PART 13: Vendor landscape

  • Competitive scenario

PART 14: Key Vendor Analysis

  • ASKA Pharmaceutical
  • Halotech DNA
  • Merck Serono
  • Zydus Cadila Healthcare
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Causes of male infertility
  • Exhibit 02: Snapshot: Global male infertility market 2016-2021
  • Exhibit 03: Stages of infertility treatment
  • Exhibit 04: Impact of various factors on male infertility market
  • Exhibit 05: Types of sperm classification
  • Exhibit 06: Global male infertility market 2016-2021 ($ millions)
  • Exhibit 07: Key parameters for vendors entering the market
  • Exhibit 08: Five forces analysis
  • Exhibit 09: Stages of diagnosis of male infertility
  • Exhibit 10: Facts related to oxidative stress
  • Exhibit 11: Global male infertility market by end-users (2016)
  • Exhibit 12: Risk factors in male infertility
  • Exhibit 13: Opportunity analysis of global male infertility market
  • Exhibit 14: Global male infertility market by geography 2016-2021
  • Exhibit 15: Snapshot: Global male infertility market by geography 2016-2021
  • Exhibit 16: Male infertility market in Americas 2016-2021 ($ millions)
  • Exhibit 17: Male infertility market in EMEA 2016-2021 ($ millions)
  • Exhibit 18: Male infertility market in APAC 2016-2021 ($ millions)
  • Exhibit 19: Estimated number of individuals with diabetes worldwide in 2015 and 2040 (millions)
  • Exhibit 20: Estimated cancer cases and deaths in US 2016 (in thousands)
  • Exhibit 21: Obesity prevalence in US 2015
  • Exhibit 22: Impact of drivers
  • Exhibit 23: Impact of challenges
  • Exhibit 24: Change in world's population by age 2010-2050
  • Exhibit 25: Key success strategies for vendors
  • Exhibit 26: ASKA Pharmaceutical profile
  • Exhibit 27: ASKA Pharmaceutical: Strength analysis
  • Exhibit 28: ASKA Pharmaceutical: Strategy assessment
  • Exhibit 29: ASKA Pharmaceutical: Opportunity assessment
  • Exhibit 30: Halotech DNA: Profile
  • Exhibit 31: Halotech DNA: Strength analysis
  • Exhibit 32: Halotech DNA: Strategy assessment
  • Exhibit 33: Halotech DNA: Opportunity assessment
  • Exhibit 34: Merck Serono: Profile
  • Exhibit 35: Merck Serono: Strength analysis
  • Exhibit 36: Merck Serono: Strategy assessment
  • Exhibit 37: Merck Serono: Opportunity assessment
  • Exhibit 38: Zydus Cadila Healthcare profile
  • Exhibit 39: ZydusCadila Healthcare: Strength analysis
  • Exhibit 40: Zydus Cadila Healthcare: Strategy assessment
  • Exhibit 41: ZydusCadila Healthcare: Opportunity assessment
Back to Top